Insider Shareholders with Direct Ownership of Aerovate Therapeutics, Inc. (AVTE)
This section provides a comprehensive overview of the insiders with direct ownership of Aerovate Therapeutics, Inc. (AVTE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Aerovate Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sofinnova Venture Partners X, L.P.
> 10% Shareholder |
3,758,686 | 0 | 3,758,686 $9.51 Million | 1 |
Jul 02, 2021
Added 8.68%
|
|
Atlas Venture Fund Xii, L.P.
> 10% Shareholder |
3,103,879 | 775,970 | 2,327,909 $5.89 Million | 3 |
Jul 15, 2022
Reduced 11.76%
|
| 418,516 | 400,997 | 14,252 $36,057 | 90 |
Aug 01, 2024
Added 9.56%
|
|
|
Hunter Gillies
CHIEF MEDICAL OFFICER |
68,255 | 68,255 | 5,602 $14,173 | 31 |
Jun 13, 2024
Reduced 51.72%
|
| 104,995 | 104,995 | 5,022 $12,705 | 34 |
Jun 14, 2024
Reduced 74.92%
|
|
|
Ralph Niven
CHIEF SCIENTIFIC OFFICER |
54,600 | 54,600 | 1,609 $4,070 | 32 |
Feb 05, 2024
Reduced 74.09%
|
|
Timothy P Noyes
CHIEF EXECUTIVE OFFICER |
150,000 | 154,180 | 0 $0 | 29 |
May 16, 2024
Reduced 100.0%
|
|
Marinus Verwijs
CHIEF TECHNICAL OFFICER |
21,200 | 26,040 | 0 $0 | 10 |
Jun 14, 2024
Reduced 100.0%
|